Wellgistics Health, Inc. is a holding company, which conducts business through two wholly owned subsidiaries, Wood Sage, LLC and Wellgistics LLC and two indirect subsidiaries, Alliance Pharma Solutions, LLC and Community Specialty Pharmacy, LLC. It focuses on specialty medications and a community-based model offering home delivery services to patients. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. Its technology platform, DelivMeds, serves as a pharmacy hub and allows for clinical services to be connected to the Company’s health pharmacy operations. This platform will allow for an end-to-end mobile application solution whereby patients can digitize their prescription journey. The solution helps to preserve patient autonomy, improve prescription price transparency, and provide additional concierge services. Its products include Kyzatrex and Semaglutide and Tirzepatide.
Wachstum
Das Unternehmen befindet sich in einer Wachstumsphase, wobei das aktuelle Jahreseinkommen insgesamt 23.34M USD beträgt.
Hohe Gewinnwachstumsrate
Das Nettoeinkommen des Unternehmens führt die Branche an, das letzte Jahres Einkommen betrug insgesamt 23.34M USD.
Unterbewertet
Die aktuelle PE1 des Unternehmens liegt bei -3.402, im niedrigen 3-Jahres-Perzentilbereich.
Gehalten von Steven Cohen
Star-Investor Steven Cohen1 hält 15.252 Aktien dieses Unternehmens.